Cormorant Asset Management, LP - PROVECTUS BIOPHARMACEUTICALS ownership

PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 41 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of PROVECTUS BIOPHARMACEUTICALS
ValueSharesWeighting
Q3 2016$221,000
-73.2%
2,226,9610.0%0.02%
-79.5%
Q2 2016$824,000
-1.4%
2,226,961
+1.2%
0.12%
-7.1%
Q1 2016$836,000
-2.6%
2,200,0000.0%0.13%
+22.3%
Q4 2015$858,000
-32.2%
2,200,0000.0%0.10%
-49.0%
Q3 2015$1,265,000
+6.5%
2,200,0000.0%0.20%
+27.8%
Q2 2015$1,188,0002,200,0000.16%
Other shareholders
PROVECTUS BIOPHARMACEUTICALS shareholders Q3 2016
NameSharesValueWeighting ↓
HOME FEDERAL BANK OF TENNESSEE 100,000$6,0000.00%
LEE DANNER & BASS INC 50,000$3,0000.00%
Ancora Advisors LLC 14,650$1,0000.00%
Diversified Trust Co 50,000$3,0000.00%
CAPTRUST FINANCIAL ADVISORS 57,659$3,0000.00%
ACADEMY CAPITAL MANAGEMENT INC/TX 20,000$1,0000.00%
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of PROVECTUS BIOPHARMACEUTICALS shareholders